Related Experiment Video
Updated: Mar 25, 2026
06:11
Brain-Computer Interface-controlled Upper Limb Robotic System for Enhancing Daily Activities in Stroke Patients
Published on: April 18, 2025
2.0K
Brain-computer interface devices for patients with paralysis and amputation: a meeting report
K Bowsher1, E F Civillico, J Coburn
1US FDA, Center for Devices and Radiological Health, Office of Device Evaluation, Silver Spring, MD, USA.
Journal of Neural Engineering
|March 1, 2016
Summary
The Food and Drug Administration (FDA) is developing regulatory guidance for brain-computer interface (BCI) devices to foster innovation while ensuring patient safety. This guidance will support the development of neuroprosthetic medical devices.
Area of Science:
- Neuroprosthetics and Medical Devices
- Brain-Computer Interface (BCI) Technology
- Regulatory Science in Healthcare
Background:
- The Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) acknowledges the need for clear regulatory pathways for innovative medical devices.
- Brain-computer interfaces (BCI) are crucial neuroprostheses that restore motor or sensory functions by interfacing with the nervous system.
- Stakeholders including manufacturers, healthcare professionals, and patients require guidance to navigate the evolving regulatory landscape.
Framework:
- A public workshop was convened on November 21, 2014, to discuss scientific and clinical considerations for BCI device development.
- The workshop aimed to foster open dialogue among diverse stakeholders on the challenges and opportunities in BCI technology.
Implementation:
- Presentations and discussions from the workshop are summarized in this paper.
- The CDRH will utilize insights from the workshop to inform the development of regulatory considerations for BCI devices.
- This initiative supports the advancement of regulatory science and stakeholder input.
Implications:
- The FDA intends to create guidance for premarket submissions of BCI devices, balancing innovation with patient protection.
- These proceedings will serve as a valuable resource for the BCI community in developing medical devices for consumers.
- The regulatory framework will promote the safe and effective integration of BCI technology into clinical practice.
